Education
About Us
Working with TipRanks
Follow Us
Gemina Laboratories Ltd. (TSE:GLAB)
:GLAB
RESEARCH TOOLSreports
GLAB Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.28 - C$1.25
Previous CloseN/A
Volume500.00
Average Volume (3M)4.93K
Market Cap
C$65.09M
Enterprise ValueN/A
Total Cash (Recent Filing)C$41.61K
Total Debt (Recent Filing)C$1.46M
Price to Earnings (P/E)―
Beta0.40
Next Earnings
Jun 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding76,570,910
10 Day Avg. Volume1,420
30 Day Avg. Volume4,926
Financial Highlights & Ratios
PEG Ratio-2.73
Price to Book (P/B)-22.82
Price to Sales (P/S)0.00
P/FCF Ratio-63.96
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Gemina Laboratories Ltd. News
PremiumCompany Announcements
Gemina Labs Raises Funds and Settles Debt
PremiumCompany Announcements
Gemina Laboratories Advances Commercial Strategy
PremiumCompany Announcements
Gemina Labs Expands Diagnostic Tech Portfolio
PremiumCompany Announcements
Gemina Labs Strikes Major Licensing Deal
PremiumCompany Announcements
Gemina Labs Advances with New Partnerships and Tech
PremiumCompany Announcements
Gemina Laboratories Secures $910K in FinancingGLAB FAQ
What was Gemina Laboratories Ltd.’s price range in the past 12 months?
Gemina Laboratories Ltd. lowest stock price was C$0.28 and its highest was C$1.25 in the past 12 months.
What is Gemina Laboratories Ltd.’s market cap?
Gemina Laboratories Ltd.’s market cap is C$65.09M.
When is Gemina Laboratories Ltd.’s upcoming earnings report date?
Gemina Laboratories Ltd.’s upcoming earnings report date is Jun 26, 2025 which is in 16 days.
How were Gemina Laboratories Ltd.’s earnings last quarter?
Currently, no data Available
Is Gemina Laboratories Ltd. overvalued?
According to Wall Street analysts Gemina Laboratories Ltd.’s price is currently Overvalued.
Does Gemina Laboratories Ltd. pay dividends?
Gemina Laboratories Ltd. does not currently pay dividends.
What is Gemina Laboratories Ltd.’s EPS estimate?
Gemina Laboratories Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Gemina Laboratories Ltd. have?
Gemina Laboratories Ltd. has 76,570,910 shares outstanding.
What happened to Gemina Laboratories Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Gemina Laboratories Ltd.?
Currently, no hedge funds are holding shares in TSE:GLAB
Gemina Laboratories Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
―
20 days / 200 days
Momentum
91.01%
12-Months-Change
Fundamentals
Return on Equity
98.62%
Trailing 12-Months
Asset Growth
-1.24%
Trailing 12-Months
Company Description
Gemina Laboratories Ltd.
Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company develops novel surface functionalization chemistries for the detection of pathogens and biomarkers. It is developing POC Antigen COVID test, a point-of-care lateral flow assay test strip to test whether or not a person is currently infected with COVID-19. The company is headquartered in Vancouver, Canada.
Technical Analysis
Oncolytics Biotech
―
Covalon Technologies
―
Microbix Biosystms
―
Medmira
―
Sernova
―